No Discovery In Regeneron FCA Case Until 1st Circ. Rules
A False Claims Act case against Regeneron Pharmaceuticals Inc. will freeze completely while the government and the company argue the appeal of a crucial legal question, the presiding judge said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article